A new device is now available for treating advanced liver cancer at home using electromagnetic waves, the Barbara Ann ...

Now, eight years later, Chris credits the treatment with saving his life, calling it nothing short of miraculous. Another ...

New DESTINY-Breast06 analysis showed trastuzumab deruxtecan doubled PFS versus chemotherapy in patients with rapid ...

The FDA approved ensartinib (Ensacove) as a first-line treatment for adults with ALK-positive locally advanced or metastatic ...

A MedUni Vienna study has identified a new approach to the drug treatment of metabolic liver diseases. In an experimental ...

It uses electromagnetic waves to target tumors and is available to patients for whom first- and second-line treatments have ...

Randomized Phase 2 study initiated evaluating the combination of casdozokitug, toripalimab and bevacizumab in patients with liver cancer ...

A MedUni Vienna study has identified a new approach to the drug treatment of metabolic liver diseases. In an experimental study, pharmacological inhibition of an enzyme that plays a central role in ...

The model uses clinical and genomic features to predict whether patients will respond to first-line CDK4/6 and endocrine therapy.

An immunofluorescence image of an aged mouse liver. Expression of β-galactosidase (white ... the primary challenge to ...

Researchers presented data from trials of HER2-targeted therapies from Jiangsu Hengrui Medicine, Jazz Pharma, Roche, and RemeGen.

Patients with heavily pretreated microsatellite stable metastatic colorectal cancer (CRC) had survival benefits after using ...